임상이비인후과 (Journal of Clinical Otolaryngology Head and Neck Surgery)

  • 제29권2호
  • /
  • Pages.290-294
  • /
  • 2018
  • /
  • 1225-0244(pISSN)
  • /
  • 2713-833X(eISSN)
대한이비인후과학회 부산,울산,경남 지부회 (The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery)
권호 표지

이하선에 발생한 유선 유사 분비성 암종 1예

A Case of Mammary Analogue Secretory Carcinoma of the Parotid Gland

  • 강민지 (경상대학교 의과대학 경상대학교병원 이비인후과학교실) ;
  • 여성철 (경상대학교 의과대학 경상대학교병원 이비인후과학교실) ;
  • 원성준 (경상대학교 의과대학 경상대학교병원 이비인후과학교실) ;
  • 박정제 (경상대학교 의과대학 경상대학교병원 이비인후과학교실)
  • Kang, Min Ji (Department of Otorhinolaryngology, Gyeongsang National University Hospital) ;
  • Yeo, Seong-Chul (Department of Otorhinolaryngology, Gyeongsang National University Hospital) ;
  • Won, Seong Jun (Department of Otorhinolaryngology, Gyeongsang National University Hospital) ;
  • Park, Jung Je (Department of Otorhinolaryngology, Gyeongsang National University Hospital)
  • 투고 : 2018.09.13
  • 심사 : 2018.11.30
  • 발행 : 2018.12.30

⟨ 이전 논문 다음 논문 ⟩

초록

Mammary analogue secretory carcinoma (MASC) has histologic similarities to not only acinic cell carcinoma but also other low grade cystadenocarcinoma, and has similar features to breast secretory carcinoma. MASC was not described through the existing classification system previously. But, MASC was distinguished from other salivary gland tumors by Skalova et al. in 2010, MASC has ets variant gene 6-neurotrophic tyrosine kinase, receptor, type 3 (ETV6-NTRK3) translocation. So far, there are 4 cases of MASC recognized in the head and neck region in Korea. One of the four is a tumor from the submandibular gland, and the other three are of the parotid gland. In this case report, we report a 40-year-old man with a MASC of the parotid gland, who presented with right infra-auricular mass.

키워드

참고문헌

  1. Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010;34(5):599-608.
  2. Boon E, Valstar MH, van der Graaf WTA, Bloemena E, Willems SM, Meeuwis CA, et al. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands. Oral Oncol 2018;82:29-33. https://doi.org/10.1016/j.oraloncology.2018.04.022
  3. Kim HT LC, Kim HS, Park HS. A case of mammary analogue secretory carcinoma arising from parotid gland. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 2015;58(8):563-6. https://doi.org/10.3342/kjorl-hns.2015.58.8.563
  4. Han SM, Park SM, Kwon HJ, Kim JH. Case report of a mammary analogue secretory carcinoma of the parotid gland. Korean Journal of Head and Neck Oncology 2017;33(2):85-8.
  5. Song CM Jung SM, Shin SJ, Tae K. Salivary gland carcinoma mimicking secretory breast cancer. Korean Journal of Head and Neck Oncology 2017;33(2):101-5. https://doi.org/10.21593/kjhno/2017.33.2.101
  6. Ban MJ, Noh MH, Choi SJ,Park JH. A Case of A Mammary Analogue Secretory Carcinoma of the Submandibular Gland Mimicking a Second Branchial Cleft Cyst. J Clinical Otolaryngol 2016;27(2):1-5.
  7. Oza N, Sanghvi K, Shet T, Patil A, Menon S, Ramadwar M, et al. Mammary analogue secretory carcinoma of parotid: Is preoperative cytological diagnosis possible? Diagn Cytopathol 2016;44(6):519-25. https://doi.org/10.1002/dc.23459
  8. Salat H, Mumtaz R, Ikram M, Din NU. Mammary Analogue Secretory Carcinoma of the Parotid Gland: A Third World Country Perspective-A Case Series. Case Rep Otolaryngol 2015;2015:697254.
  9. Sethi R, Kozin E, Remenschneider A, Meier J, VanderLaan P, Faquin W, et al. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope 2014;124(1):188-95. https://doi.org/10.1002/lary.24254
  10. Shah AA, Wenig BM, LeGallo RD, Mills SE, Stelow EB. Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma. Head Neck Pathol 2015;9(1):85-95. https://doi.org/10.1007/s12105-014-0557-1
  11. Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. American Journal of Surgical Pathology 2018;42(8):1121-6. https://doi.org/10.1097/PAS.0000000000001065
  12. Bissinger O, Gotz C, Kolk A, Bier HA, Agaimy A, Frenzel H, et al. Mammary analogue secretory carcinoma of salivary glands: diagnostic pitfall with distinct immunohistochemical profile and molecular features. Rare Tumors 2017;9(3):89-92. https://doi.org/10.4081/rt.2017.7162
  13. Rovira C, Leon X, Vasquez CP, Lopez M. Mammary analogue secretory carcinoma of salivary glands: Report of clinical case. Acta Otorrinolaringologica Espanola 2017;69(5):306-8.
  14. Baghai F, Yazdani F, Etebarian A, Garajei A, Skalova A. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin. Pathology Research and Practice 2017;213(9):1112-8. https://doi.org/10.1016/j.prp.2017.07.017
  15. Parekh V, Stevens TM. Mammary Analogue Secretory Carcinoma. Arch Pathol Lab Med 2016;140(9):997-1001. https://doi.org/10.5858/arpa.2015-0075-RS
  16. Jung MJ, Song JS. Kim SY, Nam SY, Roh JL, Choi SH, et al. Finding and characterizing mammary analogue secretory carcinoma of the salivary gland. Korean Journal of Pathology 2013;47(1):36-43. https://doi.org/10.4132/KoreanJPathol.2013.47.1.36
  17. Amit B DR, Alan S, Kenneth R. Mammary analogue secretory carcinoma of the parotid gland: A rare and unique entity. J of Otolaryngol ENT Res 2016;5(3):00140.